Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Clinical trial NCT07480941 · RECRUITING

Trial details

NCT number: NCT07480941
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma High-grade Glioma Malignant Glioma Recurrent Glioblastoma Recurrent High-grade Glioma

Start date: 2026-02-02
Primary completion: 2027-02-18
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.